Capricor Therapeutics
CAPR
CAPR
106 hedge funds and large institutions have $136M invested in Capricor Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 37 reducing their positions, and 28 closing their positions.
Holders
106
Holders Change
-14
Holders Change %
-11.67%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
40
Reduced
37
Closed
28
Calls
$47.4M
Puts
$60.7M
Net Calls
-$13.2M
Net Calls Change
-$18.7M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$1.94M |
| 2 |
2
National Bank of Canada
Montreal,
Quebec, Canada
|
$1.68M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$5.46M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$796K |
| 5 |
HSA
5
HBK Sorce Advisory
Erie,
Pennsylvania
|
$1.27M |
